Urovant is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of urologic conditions.
Business Model:
Revenue: $104.6M
Employees: 51-200
Address: 5281 California Avenue
City: Irvine
State: CA
Zip: 92617
Country: US
Urovant is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of urologic conditions.
Contact Phone:
+19492266029
Contact Email:
Listed Exchange:
NASDAQ
Ticker Symbol:
UROV
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2019 | Debt Financing | 1 | $100M |
Hercules Capital Hercules Capital Hercules Capital Hercules Capital |
12/2019 | Debt | $300M |
Sumitomo Dainippon Pharma |
9/2018 | IPO | $140M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|